• Influenza Virus Type A and B, SARS-CoV-2 (COVID-19) Antibody or Antigen
  • Chromogranin A
  • Angiosarcoma, MYC (8q24) Amplification, FISH, Tissue
  • Cystatin C, Serum
  • 11-Dehydro-Thromboxane B2, Urine
  • Sickle Cell Anemia Genetic Analysis
  • 1,3-Beta-D-Glucan (Fungitell® ß-D Glucan), Serum
  • Hepatitis A Virus (HAV) Antibody, IgM
  • Fine Needle Aspiration, Breast
  • Varicella Zoster Virus (VZV) Antibody, IgG and IgM
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Clinical Utility
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.
Loading...